Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma.
Schabath MB, Welsh EA, Fulp WJ, Chen L, Teer JK, Thompson ZJ, Engel BE, Xie M, Berglund AE, Creelan BC, Antonia SJ, Gray JE, Eschrich SA, Chen DT, Cress WD, Haura EB, Beg AA. Schabath MB, et al. Among authors: chen dt, chen l. Oncogene. 2016 Jun 16;35(24):3209-16. doi: 10.1038/onc.2015.375. Epub 2015 Oct 19. Oncogene. 2016. PMID: 26477306 Free PMC article.
In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival.
Bicaku E, Xiong Y, Marchion DC, Chon HS, Stickles XB, Chen N, Judson PL, Hakam A, Gonzalez-Bosquet J, Wenham RM, Apte SM, Fulp W, Cubitt CL, Chen DT, Lancaster JM. Bicaku E, et al. Among authors: chen dt, chen n. Br J Cancer. 2012 Jun 5;106(12):1967-75. doi: 10.1038/bjc.2012.207. Epub 2012 May 17. Br J Cancer. 2012. PMID: 22596241 Free PMC article.
Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma.
Permuth JB, Park MA, Chen DT, Basinski T, Powers BD, Gwede CK, Dezsi KB, Gomez M, Vyas SL, Biachi T, Cortizas EM, Crowder S, Genilo-Delgado M, Green BL, Greene A, Gregg C, Hoffe SE, Jiang K, Kim B, Vasudevan V, Garcialopez De Llano J, Menon AA, Mo Q, MorenoUrazan LM, Mok S, Parker N, Rajasekhara S, Rasool G, Sinnamon A, Sparks L, Stewart PA, Tardif K, Tassielli AF, Teer JK, Tran DV, Turner KL, Vadaparampil ST, Whelan CJ, Douglas WG, Velanovich V, Karachristos A, Legaspi A, Meredith K, Molina-Vega MA, Huguet KL, Arnoletti JP, Bloomston M, Trevino J, Merchant NB, Pimiento JM, Hodul PJ, Malafa M, Fleming J, Judge SM, Jeong DK, Judge A. Permuth JB, et al. Among authors: chen dt. Front Oncol. 2024 Jul 23;14:1362244. doi: 10.3389/fonc.2024.1362244. eCollection 2024. Front Oncol. 2024. PMID: 39109281 Free PMC article.
309 results